Antibodies
3 August 2007
Genmab regains rights to HuMax-TAC3 August 2007
Macrogenics Begins Global Phase 2/3 Protege Study In Recent-onset Type 1 Diabetes Mellitus2 August 2007
Phase 2a Multi-dose Study Initiated By Medimmune In Patients With Asthma To Further Expand Anti-interleukin-9 Program1 August 2007
Preliminary Data Add New Mechanistic Insights to Activity of Anthrax Anti-Toxin, Valortim(TM)1 August 2007
YM BioSciences initiates patient enrolment in phase II colorectal cancer trial with EGFR antibody26 July 2007
Actemra monotherapy demonstrates significant clinical benefit in patients with rheumatoid arthritis21 July 2007
Avastin receives positive opinion in Europe for first-line treatment of patients with advanced lung cancer19 July 2007
Medarex Announces Initiation by Licensing Partner of Phase III Clinical Trial for Muckle Wells Syndrome13 July 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung CancerNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports